SCOPINARO, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 27.374
Totale 27.374
Nazione #
IT - Italia 27.374
Totale 27.374
Città #
Genova 19.791
Rapallo 3.284
Genoa 2.374
Vado Ligure 1.886
Bordighera 39
Totale 27.374
Nome #
LA RESEZIONE GASTRICA CON GASTROENTEROANASTOMOSI SECONDO ROUX PER LA TERAPIA CHIRURGICA DELL'ULCERA GASTRICA E DUODENALE. 194
Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. 188
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 180
Biliopancreatic diversion 163
Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. 158
Biliopancreatic diversion for obesity: state of the art. 158
Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion 158
Effect of biliopancreatic diversion on hypertension in severely obese patients. 157
Three-factor Eating Questionnaire and Eating Disorder Inventory in the evaluation of psychological traits and emotional reactivity in obese patients 151
Alexithymia and eating behaviour in severely obese patients. 150
Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage 150
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 149
Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. 146
BILIO-PANCREATIC BYPASS FOR OBESITY: II. INITIAL EXPERIENCE IN MAN. 144
A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS) 143
Physical Activity After Surgically Obtained Weight Loss: Study with a SenseWear Armband in Subjects Undergoing Biliopancreatic Diversion 134
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 132
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 129
Bariatric surgery in adolescents: a long-term follow-up study 129
Quality of life in obese subjects following biliopancreatic diversion. 128
Does Biliopancreatic Diversion Carry Increased Risk for Colorectal Cancer? A Cohort Study 128
A comparison of a personal series of biliopancreatic diversion and literaturedata on gastric bypass help to explain the mechanisms of resolution of type 2diabetes by the two operations. 128
Three factor eating questionnaire and eating disorder inventory in the evaluation of psychological traits and emotional reactivity in obese persons 127
Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 127
BEHAVIORAL APPROACH TO PROMOTE EATING HABITS AND LIFESTYLE CHANGES FOLLOWING GASTRIC CHANGES FOR OBESITY 125
Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters. 125
[Role of carbohydrates in the diet of gout patients]. 125
Role of preoperative Multitest findings on predicting postoperative infectiouscomplications. 124
Interdisciplinary European guidelines for surgery for severe (morbid) obesity. 124
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 124
10 YEARS EXPERIENCE WITH BILIOPANCREATIC DIVERSION (BPD) 123
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss. 123
WERNICKE-KORSAKOFF ENCEPHALOPATHY FOLLOWING BILIOPANCREATIC DIVERSION 123
Gastric cancer and Roux-en-Y gastric bypass. 122
Colorectal cancer after biliopancreatic diversion for obesity 122
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 122
Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity 122
The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. 121
Biliopancreatic diversion for obesity at eighteen years 121
Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. 120
[A case of severe obesity treated jejunoileal bypass. 1-year clinical course]. 120
Intraluminal penetration of the band in patients with adjustable silicone gastricbanding: radiological findings. 120
The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30-35 kg/m2) and Simple Overweight (BMI 25-30 kg/m 2) A Prospective Controlled Study. 120
Relationships of serum leptin to clinical and anthropometric findings in obese patients. 119
A new approach to the fashioning of the gastroenteroanastomosis in laparoscopicstandard biliopancreatic diversion. 119
Short-term liver function after biliopancreatic diversion. 119
Radiology of patients with vertical banded gastroplasty. 119
CLINICAL USE OF PARTIAL BILIOPANCREATIC BYPASS FOR OBESITY. DETAILS OF OPERATIVE TECHNIQUE AND FOLLOW-UP MANAGEMENT. 119
Preoperative resting energy expenditure does not predict weight loss and maintenance after vertical banded gastroplasty. 118
Orally-administered Serum Ranitidine Concentration after BiliopancreaticDiversion for Obesity. 118
Binge eating in massively obese patients undergoing bariatric surgery. 118
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 118
[Aspects ofneurohypophysial function in the course of hyperthyroidism]. 116
Resting Energy Expenditure in long-term postobese subjects after weight normalization by dieting or biliopancreatic diversion 114
Editors' comment: bariatrics and diabetes meta-analysis. 114
Effects of Gastric Bypass on Type 2. Diabetes in Patients with BMI 30 to 35 114
Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35kg/m2: an integrative review of early studies. 114
Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. 114
Biliopancreatic diversion reduces QT interval and dispersion in severely obese patients. 114
Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. 113
Eating Disorder Inventory in the assessment of psychosocial status in the obese patients prior to and at long term following biliopancreatic diversion for obesity 113
Serum leptin concentration in obese patients with binge eating disorder. 112
Why the Operation I Prefer is Biliopancreatic Diversion (BPD). 111
Interdisciplinary European guidelines on surgery of severe obesity. 111
HAIR AND PLASMA ZINC LEVELS FOLLOWING EXCLUSION OF BILIOPANCREATIC SECRETIONS FROM FUNCTIONING GASTROINTESTINAL TRACT IN HUMANS. 111
Night eating and binge eating disorder in obese patients. 111
Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and cardiovascular parameters. 109
Biliopancreatic diversion: mechanisms of action and long-term results. 109
Body image and body weight in obese patients 109
BILIOPANCREATIC DIVERSION 108
Body composition and energy expenditure in obese patients prior to and following biliopancreatic diversion for obesity. 108
Intravenous nutritional support in pregnancy. Experience followingbiliopancreatic diversion. 108
Pregnancy in Formerly Type 2 Diabetes Obese WomenFollowing Biliopancreatic Diversion for Obesity 107
Laparoscopic standard biliopancreatic diversion: technique and preliminaryresults. 107
Energy and nitrogen absorption after biliopancreatic diversion 107
BONE HISTOMORPHOMETRY AND VITAMIN D STATUS AFTER BILIOPANCREATIC BYPASS FOR OBESITY. 106
[Orotic acid and hyperuricemia caused by fructose] 106
Small-intestinal and colonic changes after biliopancreatic bypass for morbidobesity. 106
Leptin and HDL-cholesterol in non-diabetic normotensive subjects. 106
Interdisciplinary European guidelines on metabolic and bariatric surgery. 106
Interdisciplinary European Guidelines on metabolic and bariatric surgery 106
Obese binge eaters: metabolic characteristics, energy expenditure and dieting 105
INTRALUMINAL PENETRATION OF THE BAND IN PATIENTS WITH ADJUSTABLE SILICONE GASTRIC BAMDING: REDIOLOGICAL FINDINGS 105
In vivo evaluation of immunological status after biliopancreatic bypass. 105
Can a protocol for glycaemic control improve type 2 diabetes outcomes aftergastric bypass? 105
An invitation to our medical colleagues: work with us. 104
Body image in binge eating disorder. 103
[Action of parathormone on the urinary excretion of mono- and bivalent cations in man]. 103
Sub-clinical organ damage in hypertension and obesity 103
Short-term changes in serum leptin concentration following biliopancreatic diversion 102
[Behavior of urinary excretion of monoand bi-valent cations after intravenous overload of calcium]. 102
Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. 102
Satiety after vertical banded gastroplasty 102
Plasma ghrelin concentratin in the short-term following biliopancreaticdiversion. 101
Pregnancies in an 18-year follow-up after biliopancreatic diversion 101
Biliopancreatic Diversion. 100
PROTEIN-MALNUTRITION AFTER BILIOPANCREATIC DIVERSION (BPD) 100
Pouch diverticula after vertical-banded gastroplasty. 100
'Simple' form of Caroli's disease 99
liver morphology and function after biliopancreatic bypass 99
Totale 12.075
Categoria #
all - tutte 76.985
article - articoli 74.791
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.194
Totale 153.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.160 0 0 0 0 0 598 1.174 322 575 1.402 777 312
2020/20211.671 138 85 190 138 58 217 106 102 236 124 140 137
2021/20223.753 66 358 226 525 162 204 295 814 132 373 96 502
2022/20233.930 420 178 27 432 628 784 8 380 655 22 335 61
2023/20241.592 103 227 18 185 114 346 38 82 83 48 117 231
2024/20252.061 101 383 174 263 661 479 0 0 0 0 0 0
Totale 27.441